Less Ads, More Data, More Tools Register for FREE

Pin to quick picksATK.L Regulatory News (ATK)

  • There is currently no data for ATK

Form 8.3 - WS ATKINS PLC

30 May 2017 10:29

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser: Barclays PLC.
(b) Owner or controller of interest and short
positions disclosed, if different from 1(a):
(c) Name of offeror/offeree in relation to whose WS ATKINS PLC
relevant securities this form relates:
(d) If an exempt fund manager connected with an
offeror/offeree, state this and specify identity of
offeror/offeree:
(e) Date position held/dealing undertaken: 26 May 2017
(f) In addition to the company in 1(c) above, is the discloser making NO
disclosures in respect of any other party to the offer?

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: ORD
Interests Short Positions
Number (%) Number (%)
(1) Relevant securities owned
and/or controlled: 1,145,541 1.14% 962,567 0.96%
(2) Cash-settled derivatives:
21,309 0.02% 979,505 0.98%
(3) Stock-settled derivatives (including options)
and agreements to purchase/sell: 0 0.00% 0 0.00%
TOTAL: 1,166,850 1.17% 1,942,072 1.94%

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant

Purchase/sale Number of Price per unit
security securities
5p ORD Purchase 36 20.8500 GBP
5p ORD Purchase 59 20.8950 GBP
5p ORD Purchase 81 20.8912 GBP
5p ORD Purchase 217 20.8750 GBP
5p ORD Purchase 321 20.8650 GBP
5p ORD Purchase 476 20.8713 GBP
5p ORD Purchase 480 20.8850 GBP
5p ORD Purchase 508 20.9000 GBP
5p ORD Purchase 680 20.8761 GBP
5p ORD Purchase 1,055 20.8816 GBP
5p ORD Purchase 1,338 20.8700 GBP
5p ORD Purchase 1,525 20.8879 GBP
5p ORD Purchase 2,316 20.8852 GBP
5p ORD Purchase 2,362 20.8900 GBP
5p ORD Purchase 2,984 20.8800 GBP
5p ORD Purchase 3,056 20.8794 GBP
5p ORD Purchase 5,737 20.8803 GBP
5p ORD Purchase 6,774 20.8469 GBP
5p ORD Purchase 8,251 20.8190 GBP
5p ORD Purchase 11,311 20.8529 GBP
5p ORD Purchase 11,477 20.8638 GBP
5p ORD Sale 36 20.8500 GBP
5p ORD Sale 40 20.8520 GBP
5p ORD Sale 59 20.8950 GBP
5p ORD Sale 217 20.8750 GBP
5p ORD Sale 321 20.8650 GBP
5p ORD Sale 508 20.9000 GBP
5p ORD Sale 614 20.9001 GBP
5p ORD Sale 822 20.8850 GBP
5p ORD Sale 1,393 20.8728 GBP
5p ORD Sale 1,915 20.8700 GBP
5p ORD Sale 2,362 20.8900 GBP
5p ORD Sale 2,973 20.8800 GBP
5p ORD Sale 4,437 20.8763 GBP
5p ORD Sale 7,387 20.8854 GBP
5p ORD Sale 13,881 20.8664 GBP
5p ORD Sale 23,148 20.8460 GBP

(b) Cash-settled derivative transactions

Class of Product Nature of dealing Number of Price per
relevant description reference unit
security securities
5p ORD SWAP Long 167 20.9200 GBP
5p ORD SWAP Long 407 20.8722 GBP
5p ORD SWAP Long 1,393 20.8729 GBP
5p ORD SWAP Long 1,824 20.9116 GBP
5p ORD SWAP Long 2,347 20.8438 GBP
5p ORD CFD Long 2,819 20.8766 GBP
5p ORD CFD Long 2,923 20.8746 GBP
5p ORD CFD Long 4,437 20.8763 GBP
5p ORD SWAP Short 59 20.8800 GBP
5p ORD CFD Short 81 20.8912 GBP
5p ORD SWAP Short 701 20.8861 GBP
5p ORD SWAP Short 1,665 20.8768 GBP
5p ORD SWAP Short 2,402 20.8922 GBP
5p ORD SWAP Short 13,945 20.8557 GBP

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type

e.g. American, European etc.

Expiry date Option money paid/ received per unit

(ii) Exercise

Class of relevant security Product description

e.g. call option

Exercising/ exercised against Number of securities Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing

e.g. subscription, conversion

Details Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 30 May 2017
Contact name: Hemika Mistry
Telephone number: 020 7116 3891

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170530005510/en/

Copyright Business Wire 2017

Date   Source Headline
4th Apr 20173:06 pmRNSForm 8.3 - [WS Atkins plc]
4th Apr 20172:57 pmRNSForm 8.3 - Atkins (WS)
4th Apr 20172:56 pmRNSForm 8.3 - WS Atkins Plc
4th Apr 20172:32 pmRNSForm 8.3 - ATKINS (WS) PLC
4th Apr 20171:17 pmRNSForm 8.3 - WS Atkins PLC
4th Apr 201712:39 pmRNSForm 8.3 - WS Atkins plc
4th Apr 201712:39 pmPRNForm 8.3 - WS Atkins PLC
4th Apr 201711:53 amRNSForm 8.3 -Atkins (WS) Plc
4th Apr 201711:40 amRNSForm 8.5 (EPT/RI) - WS Atkins
4th Apr 201710:59 amRNSForm 8.3 - WS Atkins PLC
4th Apr 201710:34 amRNSForm 8.5 (EPT/RI) - Atkins (WS) Plc
3rd Apr 20172:55 pmRNSForm 8.3 - WS Atkins Plc
3rd Apr 20171:18 pmRNSStatement re Possible Offer
28th Mar 20177:00 amRNSAnalyst Presentation
17th Mar 20177:00 amRNSDirector/PDMR Shareholding
16th Feb 20174:51 pmRNSDirector/PDMR Shareholding
8th Feb 20177:00 amRNSTrading Statement
20th Jan 20174:23 pmRNSHolding(s) in Company
18th Jan 20173:06 pmRNSHolding(s) in Company
18th Jan 20172:58 pmRNSDirector/PDMR Shareholding
12th Jan 20176:04 pmRNSDirector/PDMR Shareholding
19th Dec 20163:58 pmRNSDirector/PDMR Shareholding
24th Nov 20165:10 pmRNSDirector/PDMR Shareholding
24th Nov 20165:02 pmRNSDirector/PDMR Shareholding
22nd Nov 20164:06 pmRNSDirector/PDMR Shareholding
21st Nov 20164:26 pmRNSDirector/PDMR Shareholding
17th Nov 20164:48 pmRNSDirector/PDMR Shareholding
17th Nov 20167:00 amRNSHalf-year Report
14th Nov 20167:00 amRNSDirectorate Change
19th Oct 20165:56 pmRNSDirector/PDMR Shareholding
3rd Oct 20164:06 pmRNSHolding(s) in Company
30th Sep 20167:00 amRNSCapital Markets event
29th Sep 20167:00 amRNSTrading Statement
28th Sep 20163:38 pmRNSDirector/PDMR Shareholding
19th Sep 20165:44 pmRNSDirector/PDMR Shareholding
31st Aug 20161:37 pmRNSDirector/PDMR Shareholding
25th Aug 20165:24 pmRNSDirector/PDMR Shareholding
18th Aug 20164:00 pmRNSDirector/PDMR Shareholding
17th Aug 20165:59 pmRNSDirector/PDMR Shareholding
17th Aug 20165:58 pmRNSDirector/PDMR Shareholding
17th Aug 20165:49 pmRNSDirector/PDMR Shareholding
15th Aug 20165:00 pmRNSDirector/PDMR Shareholding
8th Aug 20162:28 pmRNSHolding(s) in Company
5th Aug 201611:03 amRNSNational Storage Mechanism filing
3rd Aug 20167:00 amRNSResult of AGM
2nd Aug 20167:00 amRNSTrading Statement
18th Jul 20166:23 pmRNSDirector/PDMR Shareholding
18th Jul 20166:22 pmRNSDirector/PDMR Shareholding
18th Jul 20166:22 pmRNSDirector/PDMR Shareholding
18th Jul 20166:21 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.